-
2022-502135-19-00
4
2024-07-18
Calcific Aortic Valve Stenosis
-
2023-505700-35-00
4
2024-07-16
Non-Small Cell Lung Cancer with an EGFR driver mutation.
-
2024-511532-27-00
4
2024-07-07
human immunodeficiency virus 1 (HIV-1)
-
2022-500210-26-00
5
2024-06-28
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
-
2024-511072-33-00
4
2024-06-12
Chronic Lymphocytic Leukemia
-
2022-502404-73-00
4
2024-06-03
Pancreatic ductal adenocarcinoma
-
2022-502968-20-02
4
2024-05-30
Behcet's disease
-
2023-507871-23-00
5
2024-05-27
Relapsed/Refractory Multiple Myeloma
-
2023-507352-72-00
6
2024-05-24
Crohn's Disease
-
2024-511805-42-00
4
2024-05-23
Cardiogenic shock
-
2023-503241-63-00
10
2024-05-21
Urinary tract imaging
-
2023-508586-33-00
5
2024-05-14
multiple myeloma
-
2023-504143-14-00
6
2024-05-02
Chronic pancreatitis
-
2023-507632-20-00
5
2024-05-01
Multiple Myeloma
-
2023-503317-29-00
5
2024-04-12
Metastatic renal cell carcinoma (mRCC)
-
2023-505871-63-00
5
2024-04-08
ER+, HER2- metastatic breast cancer following endocrine and CDK 4/6 in
-
2023-504899-25-00
5
2024-04-04
Metastatic castration resistant prostate cancer
-
2023-505221-14-00
4
2024-04-04
Multiple Myeloma
-
2023-503412-33-00
5
2024-03-29
Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cance
-
2023-505267-36-00
5
2024-03-15
Glioblastoma
-
2023-504735-41-00
5
2024-03-05
Moderately to Severely Active Crohn's Disease
-
2023-506792-94-00
11
2024-03-04
Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
-
2024-510892-40-00
6
2024-02-29
Acute myocardial infarction complicated by cardiogenic shock
-
2023-505839-12-01
5
2024-02-26
Severe asthma